Vinpocetine
Selective Ca2+-calmodulin dependent cGMP-phosphodiesterase (PDE1) inhibitor. Shows vasorelaxant activity. Neuroprotective agent. Selectively inhibits voltage-sensitive 2+ channels Potent anti-inflammatory agent. Inhibitor of NF-kappaB-dependent inflammatory responses by directly targeting IKK. Shown to inhibit the NLRP3 inflammasome. Antioxidant. Free radical scavenger. Anticancer compound. Anticonvulsant.
| Catalog Number | AG-CN2-0454-M100 |
| Alternative Name(s) | (3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl ester; Ethyl apovincaminate; RGH-4405; TCV 3B; AY 27255 |
| Research Area | Biochemicals, Inflammasomes, Inflammation, Metabolism, Natural Products, Neurodegenerative Disease |
| Molecular Formula | C22H26N2O2 |
| CAS# | 42971-09-5 |
| Purity | >98% |
| Inchi | InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1 |
| Inchi Key | DDNCQMVWWZOMLN-IRLDBZIGSA-N |
| SMILES | [H][C@]12N3CCC[C@@]1(CC)C=C(N1C4=C(C=CC=C4)C(CC3)=C21)C(=O)OCC |
| Size | 100 mg |
| Supplier Page | http://www.adipogen.com/ag-cn2-0454/vinpocetine.html |